AI and quality Leverage Welocalize Life Sciences’ AI-led quality assurance (AILQA) and AI-powered translation quality assessment capabilities to offer faster, scalable multilingual deliverables for regulated life sciences content, appealing to pharma, CROs, and medical device firms seeking compliant, high-quality localization.

Regulatory focus Highlight proven regulatory compliance outcomes and industry-specific translations to prospective clients in regulated environments (pharmaceuticals, clinical trials, healthcare) where strict quality standards drive adoption and retention.

Enterprise-scale ops Position Opal and AI-enabled workflows as a differentiator for enterprise-scale multilingual programs, offering efficiency gains, cost reductions, and improved data models to large life sciences organizations with global localization needs.

Industry partnerships Capitalize on strategic partnerships and recognition, such as AI Excellence awards and collaborations with associations like GALA, to build credibility with large pharma and biotech companies seeking trusted language service providers.

Growth through events Target outreach around recent and upcoming industry events (EAMT, AI awards, etc.) to generate opportunities with attendees and organizations actively exploring AI-enabled localization and AI-assisted QA for regulated content.